. 1995 Jan;164(1):11-5; discussion 16-7.
doi: 10.2214/ajr.164.1.7527995.
Medical therapy for benign prostatic hyperplasia
Affiliations
- PMID: 7527995
- DOI: 10.2214/ajr.164.1.7527995
Item in Clipboard
Medical therapy for benign prostatic hyperplasia
AJR Am J Roentgenol.
1995 Jan.
Abstract
Benign prostatic hyperplasia (BPH) is a common clinical entity in elderly men. We review the epidemiology of BPH and the mechanisms by which it causes bladder outlet obstruction. The currently available medical therapies are examined with respect to mechanism of action, effectiveness, side effects, and cost. They are briefly compared with the more traditional treatment options of watchful waiting and transurethral prostatectomy. A logical approach to the treatment of symptomatic BPH is discussed.
Similar articles
-
The American Urological Association symptom score in the evaluation of men with lower urinary tract symptoms: at 2 years of followup, does it work?J Urol. 1996 Jun;155(6):1971-4. J Urol. 1996. PMID: 8618299
-
Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.Clin Pract Guidel Quick Ref Guide Clin. 1994 Feb;(8):1-17. Clin Pract Guidel Quick Ref Guide Clin. 1994. PMID: 7507389
-
Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.Urology. 1997 Dec;50(6):901-5. doi: 10.1016/S0090-4295(97)00453-6. Urology. 1997. PMID: 9426721
-
Treatment of benign prostatic hyperplasia: surgery, medical therapy, or watchful waiting.Compr Ther. 1996 Sep;22(9):554-8. Compr Ther. 1996. PMID: 8902346 Review. No abstract available.
-
Benign prostatic hyperplasia. Practical treatment guidelines.Drugs Aging. 1997 May;10(5):349-66. doi: 10.2165/00002512-199710050-00004. Drugs Aging. 1997. PMID: 9143856 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
